Amanda Corey serves as a Risk Evaluation and Mitigation Strategy (REMS) Coordinator at Biogen, where she plays a pivotal role in ensuring patient safety and compliance within the biopharmaceutical landscape. With a strong commitment to patient advocacy, Amanda champions seamless access to critical medications, employing...
Amanda Corey serves as a Risk Evaluation and Mitigation Strategy (REMS) Coordinator at Biogen, where she plays a pivotal role in ensuring patient safety and compliance within the biopharmaceutical landscape. With a strong commitment to patient advocacy, Amanda champions seamless access to critical medications, employing a patient-first approach that prioritizes the unique needs of individuals navigating complex treatment pathways. Her expertise in customer relations and patient education enables her to develop and deliver clear, comprehensive information about biotech products, empowering both patients and healthcare providers with the knowledge they need to make informed decisions.
In her current role, Amanda manages multiple territories, meticulously ensuring that the health status of every patient within her region is accurately recorded and monitored. She excels in identifying areas of non-compliance, utilizing her strong communication skills to collaborate effectively with field-based employees and various workgroups. By employing a mix of inbound and outbound calls, as well as email and fax communications, she facilitates timely escalation and resolution of issues, ensuring that patient care remains uninterrupted.
Amanda’s proficiency in data analysis and visualization allows her to track authorization statuses and compliance metrics, driving continuous improvement in patient services. Her attention to detail and adherence to Good Manufacturing Practices (GMP) further enhance her ability to manage customer-focused service initiatives effectively. As a Salesforce Case Management user, she leverages technology to streamline processes, ensuring that patient needs are met with empathy and efficiency. Through her dedication and innovative approach, Amanda Corey is not only a key player in Biogen’s REMS initiatives but also a vital advocate for patients in the biopharmaceutical industry.
